March 19, 2019 BORDEAUX, France & BOSTON–(BUSINESS WIRE)–Regulatory News: IMPLANET (Paris:ALIMP) (OTCQX:IMPZY) (Euronext Growth: ALIMP, FR0010458729, eligible for PEA-PME equity savings plans), a medical technology company specializing in vertebral and knee surgery implants, has announced that it has received 510(k) authorization from the Food and Drug Administration (FDA) for its JAZZ Cap® System, designed to …